Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Tracheloside significantly decreases the activity of alkaline phosphatase (IC50: 0.31 μg/ml), a level of inhibition comparable to that of tamoxifen (IC50: 0.43 μg/ml).
Description | Tracheloside significantly decreases the activity of alkaline phosphatase (IC50: 0.31 μg/ml), a level of inhibition comparable to that of tamoxifen (IC50: 0.43 μg/ml). |
Targets&IC50 | tamoxifen:0.43 μg/ml, alkaline phosphatase:0.31 μg/ml |
Molecular Weight | 550.557 |
Formula | C27H34O12 |
CAS No. | 33464-71-0 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 10 mM
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tracheloside 33464-71-0 代谢 内分泌与激素 Estrogen Receptor/ERR Phosphorylase antiestrogenic proliferation healing wound inhibit Inhibitor lignin keratinocyte inhibitor